170438 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving cytokines; Interleukins [IL] IL-2
MMP-14 OR TIMP POTENCY ASSAY FOR MESENCHYMAL STEM CELLS
#2NEUTRALIZATION ANTIBODY ASSAY METHOD
#3NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#4BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS
#5METHOD FOR EVALUATING QUALITY OF INDUCEMENT INHIBITORY-T-CELL FORMULATION
#6COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES
#7COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY
#8TREATMENT OF AGING FRAILTY COMPRISING ADMINISTERING BONE MARROW DERIVED MESENCHYMAL STEM CELLS
#9FUNCTIONAL CELL-BASED POTENCY ASSAY FOR MEASURING BIOLOGICAL ACTIVITY OF INTERLEUKIN 2 (IL-2) ANALOGS
#10BATCH RELEASE ASSAY FOR PHARMACEUTICAL PRODUCTS RELATING TO T CELL THERAPIES
#11COMPOSITION COMPRISING INHIBITOR AGAINST EXPRESSION OF EXOSOMAL PD-L1 AS ACTIVE INGREDIENT FOR ENHANCING ANTICANCER EFFECT
#12CHIMERIC RECEPTOR POLYPEPTIDE AND METHODS OF ACTIVATION THEREOF
#13Methods of Determining Immune Response
#14LAG3 ANTAGONIST CELL BASED POTENCY ASSAY
#15METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#16METHODS AND KITS FOR DIAGNOSING MILD COGNITIVE IMPAIRMENT
#17METHODS AND DEVICES FOR THE PRODUCTION AND DELIVERY OF BENEFICIAL FACTORS FROM STEM CELLS
#18SELECTION OF T CELL RECEPTORS
#19COMPOSITIONS AND METHODS FOR ENHANCING MUCOSAL IMMUNITY
#20METHODS OF DIAGNOSING TUBERCULOSIS AND DIFFERENTIATING BETWEEN ACTIVE AND LATENT TUBERCULOSIS
#21USE OF PERIPHERAL BLOOD PRO- AND ANTI-INFLAMMATORY CYTOKINE RATIOS AS MARKERS OF IMPLANTATION PRECEDING PREGNANCY
#22BIOMARKER PANELS FOR ON-TREATMENT PREDICTION OF RESPONSE TO IMMUNO-ONCOLOGY DRUGS
#23ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
#24Methods of immunotherapy
#25DROPLET ARRAYS FOR DETECTION AND QUANTIFICATION OF ANALYTES
#26METHODS AND COMPOSITIONS FOR ENHANCING IMMUNOASSAYS
#27METHOD FOR MEASURING SYSTEMIC CHRONIC INFLAMMAGING
#28Method for evaluating immunogenicity of test substance
#29DOSAGE OF A GLUTEN PEPTIDE COMPOSITION
#30Peptide Libraries and Methods of Use
#31Materials and methods for subjects at risk for viral reactivation
#32IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#33Assay for detecting TH1 and TH2 cell populations
#34BIOMARKERS
#35CNS Antigen-Specific B Cell and Antibody Assays in Multiple Sclerosis
#36METHODS FOR THE DIAGNOSTIC OF AN AUTOIMMUNE DISEASE
#37METHODS OF DETERMINING RELATIVE POTENCY OF GLATIRAMER ACETATE AND USE THEREOF IN PREPARING A BATCH OF GLATIRAMER ACETATE AS ACCEPTABLE FOR PHARMACEUTICAL USE
#38Methods and compositions for enhancing immunoassays
#39Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
#40Treatment with an IL-2 based therapy
#41METHODS OF TREATING WITH TUMOR MEMBRANE VESICLE-BASED IMMUNOTHERAPY AND PREDICTING THERAPEUTIC RESPONSE THERETO
#42NOVEL DESIGN OF ENZYME-LINKED IMMUNOSORBENT ASSAY PLATES AND SYSTEMS AND METHODS OF USE THEREOF
#43Antibodies to human programmed death receptor PD-1
#44Detecting Dementia and Alzheimer's Disease Associated Biomarkers Stabilized on Solid Support Materials
#45IMMUNOREGULATORY STRUCTURES FROM NORMALLY OCCURING PROTEINS
#46METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#47METHOD FOR ENHANCING IMMUNE CELL FUNCTION AND METHOD FOR ASSESSING IMMUNE CELL MULTIFUNCTIONALITY
#48METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION
#49ELISPOT method having two filter systems
#50Methods for treating medical conditions by anti-type 2 therapy
#51USE OF INTERLEUKIN-2 FOR DIAGNOSIS OF CELIAC DISEASE
#52Assay for detecting Th1 and Th2 cell populations
#53METHODS FOR DIAGNOSIS AND PROGNOSIS OF INFLAMMATORY BOWEL DISEASE USING CYTOKINE PROFILES
#54METHODS OF MEASURING ANTIGEN-SPECIFIC T CELLS
#55IL-2 peptide derivatives, and uses thereof for the diagnosis and treatment of an autoimmune disease
#56METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#57Immune monitoring to predict and prevent infection
#58Use of telmisartan to prevent and treat graft versus host disease and other alloimmune and autoimmune diseases
#59Antibodies to human programmed death receptor PD-1
#60Dosage of a gluten peptide composition
#61Suppression of cytokine release and cytokine storm
#62Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#63Methods of treating malignant tumors
#64PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#65Method and biomarkers for the detection of dengue hemorrhagic fever
#66Protein detection via nanoreporters
#67METHODS OF TREATING IPEX SYNDROME USING TOXIN-BASED PHARMACEUTICAL COMPOSITIONS
#68ELISPOT method having two filter systems
#69Method for the detection of an albumin isoform
#70Methods for determining the risk of acute graft versus host disease
#71Diagnosis and risk stratification of bladder cancer
#72Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate
#73ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
#74Methods for detecting organisms and enzymatic reactions using raman spectroscopy and aromatic compounds comprising phosphate
#75Status of Tuberculosis Infection in an Individual
#76Biomarkers
#77In-vitro process for the quick determination of a patient's status relating to infection with
#78Biomarkers for Tuberculosis and HIV/AIDS
#79Methods and compositions for enhancing immunoassays
#80Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#81Methods for diagnosing degenerative joint disease
#82Methods for differentiating between disease states
#83Neoadjuvant treatment of cancer with proleukin
#84Methods and biomarkers for the detection of dengue hemorrhagic fever
#85PROCESS FOR THE MEASUREMENT OF THE POTENCY OF GLATIRAMER ACETATE
#86STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#87Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
#88Mutant interleukin-2 (IL-2) polypeptides
#89Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#90Methods of immunoregulation by albumin neo-structures
#91Process for the measurement of the potency of glatiramer acetate
#92Protein detection via nanoreporters
#93STROMAL INTERACTING MOLECULE KNOCKOUT MOUSE AND USES THEREOF
#94Antibodies to human programmed death receptor PD-1
#95ELISPOT method having two filter systems
#96METHODS FOR DETECTING ORGANISMS AND ENZYMATIC REACTIONS USING RAMAN SPECTROSCOPY AND AROMATIC COMPOUNDS COMPRISING PHOSPHATE
#97Mutant interleukin-2 (IL-2) polypeptides
#98Method for Determining Bioactivity of Molecules
#99Clinical correlates
#100Molecular phenotyping of severe asthma
#101Process for the measurement of the potency of glatiramer acetate
#102Cd4+ Cd25+ T-cells activated to a specific antigen
#103Enhancement of Th2-Dependent and Inflammatory Response
#104Modulation of IL-2 production by T-bet
#105Interleukin-2 muteins
#106In vitro test system for predicting patient tolerability of therapeutic agents
#107Combinatorial interleukin-2 muteins
#108Novel method of selecting immunosuppressant having little thrombocytopenic effect
#109Mutant interleukin-2 (IL-2) polypeptides
#110Novel complementing receptor-ligand pairs and adoptive immunotherapy using the same
#111Fusion protein, cells expressing the fusion protein, and uses thereof